Skip to Main Content

Author Details

Matthew T Wheeler
Stanford University School of Medicine
1999
134
33
PMIDPaper TitleJournal TitlePublished Year
36481303A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network.Genet Med2023
36404399Effect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.Eur J Heart Fail2023
37850394Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol.Circulation2023
37672268Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.JAMA Cardiol2023
37653044A defect in mitochondrial fatty acid synthesis impairs iron metabolism and causes elevated ceramide levels.Nat Metab2023
37794870Personalized digital behaviour interventions increase short-term physical activity: a randomized control crossover trial substudy of the MyHeart Counts Cardiovascular Health Study.Eur Heart J Digit Health2023
37868038The functional impact of rare variation across the regulatory cascade.Cell Genom2023
36718638Plain Language Summary of Publication of the safety and efficacy of ARRY-371797 in people with dilated cardiomyopathy and a faulty <i>LMNA</i> gene.Future Cardiol2023
36713248Beyond the exome: what's next in diagnostic testing for Mendelian conditions.ArXiv2023
36652223Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized Trial.JAMA Cardiol2023
36515663Efficacy and Safety of ARRY-371797 in <i>LMNA</i>-Related Dilated Cardiomyopathy: A Phase 2 Study.Circ Genom Precis Med2023
37405726Assessment of Oxygen Pulse in Hypertrophic Cardiomyopathy-Reply.JAMA Cardiol2023
36711881The mitochondrial multi-omic response to exercise training across tissues.bioRxiv2023
36642055Generation of two human iPSC lines with Exon 3 mutations in BCL2-Associated Athanogene 3 (BAG3) from dilated cardiomyopathy patients.Stem Cell Res2023
37137577The Reply.Am J Med2023
36481303A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network.Genet Med2023
36999957Transforming Growth Factor-β Analysis of the VANISH Trial Cohort.Circ Heart Fail2023
36938756Effectiveness of the <i>Family Heart Talk</i> Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial.Circulation2023
36548481Intrinsic Atrial Myopathy Precedes Left Ventricular Dysfunction and Predicts Atrial Fibrillation in <i>Lamin A/C</i> Cardiomyopathy.Circ Genom Precis Med2023
37225358Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives.J Am Coll Cardiol2023
37541186Beyond the exome: What's next in diagnostic testing for Mendelian conditions.Am J Hum Genet2023
37526719Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European Ancestry.JAMA2023
37526719Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European Ancestry.JAMA2023
37850394Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol.Circulation2023
37794870Personalized digital behaviour interventions increase short-term physical activity: a randomized control crossover trial substudy of the MyHeart Counts Cardiovascular Health Study.Eur Heart J Digit Health2023
37653044A defect in mitochondrial fatty acid synthesis impairs iron metabolism and causes elevated ceramide levels.Nat Metab2023
37541186Beyond the exome: What's next in diagnostic testing for Mendelian conditions.Am J Hum Genet2023
37868038The functional impact of rare variation across the regulatory cascade.Cell Genom2023
37672268Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.JAMA Cardiol2023
37405726Assessment of Oxygen Pulse in Hypertrophic Cardiomyopathy-Reply.JAMA Cardiol2023
37137577The Reply.Am J Med2023
36999957Transforming Growth Factor-β Analysis of the VANISH Trial Cohort.Circ Heart Fail2023
37225358Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives.J Am Coll Cardiol2023
36652223Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized Trial.JAMA Cardiol2023
36548481Intrinsic Atrial Myopathy Precedes Left Ventricular Dysfunction and Predicts Atrial Fibrillation in <i>Lamin A/C</i> Cardiomyopathy.Circ Genom Precis Med2023
36404399Effect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.Eur J Heart Fail2023
36718638Plain Language Summary of Publication of the safety and efficacy of ARRY-371797 in people with dilated cardiomyopathy and a faulty <i>LMNA</i> gene.Future Cardiol2023
36515663Efficacy and Safety of ARRY-371797 in <i>LMNA</i>-Related Dilated Cardiomyopathy: A Phase 2 Study.Circ Genom Precis Med2023
36713248Beyond the exome: what's next in diagnostic testing for Mendelian conditions.ArXiv2023
36711881The mitochondrial multi-omic response to exercise training across tissues.bioRxiv2023
36642055Generation of two human iPSC lines with Exon 3 mutations in BCL2-Associated Athanogene 3 (BAG3) from dilated cardiomyopathy patients.Stem Cell Res2023
36938756Effectiveness of the <i>Family Heart Talk</i> Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial.Circulation2023
34173780Findings From Cardiovascular Evaluation of National Collegiate Athletic Association Division I Collegiate Student-Athletes After Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection.Clin J Sport Med2022
36309100Premature ventricular contractions (PVCs) in young athletes.Prog Cardiovasc Dis2022
36042219Deconvoluting complex correlates of COVID-19 severity with a multi-omic pandemic tracking strategy.Nat Commun2022
35700631Generation of two induced pluripotent stem cell lines carrying the phospholamban R14del mutation for modeling ARVD/C.Stem Cell Res2022
355007902022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders.Heart Rhythm2022
36270069Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying TTN mutations.Stem Cell Res2022
35671065Wnt Signaling Interactor WTIP (Wilms Tumor Interacting Protein) Underlies Novel Mechanism for Cardiac Hypertrophy.Circ Genom Precis Med2022
34173780Findings From Cardiovascular Evaluation of National Collegiate Athletic Association Division I Collegiate Student-Athletes After Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection.Clin J Sport Med2022
  • 1 - 50 of 268

Recommended Authors

Vanderbilt University Medical Center
Career Start Year 2013
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 1
Center for Genetic Medicine, Northwestern University Feinberg School of Medicine
Career Start Year 2010
Number of shared co-authors 5
Broad Institute of MIT and Harvard
Career Start Year 2009
Number of shared co-authors 12
University of Washington
Career Start Year 2008
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 13
Mayo Clinic
Career Start Year 2005
Number of shared co-authors 1
Mayo Clinic, Windland Smith Rice Genetic Heart Rhythm Clinic)
Career Start Year 2005
Number of shared co-authors 8
Heart Institute, Cincinnati Children's Hospital Medical Center
Career Start Year 2003
Number of shared co-authors 3
Duke Molecular Physiology Institute
Career Start Year 2002
Number of shared co-authors 20
Vanderbilt University
Career Start Year 2001
Number of shared co-authors 2
Cumming School of Medicine, University of Calgary, 0 Hospital Drive NW
Career Start Year 2000
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 6
Medical College of Wisconsin
Career Start Year 1998
Number of shared co-authors 13
and Cardiovascular Research Institute, University of California davis
Career Start Year 1998
Number of shared co-authors 0
Maastricht University Medical Centre
Career Start Year 1998
Number of shared co-authors 2
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 15
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 7
Hospital for Sick Children
Career Start Year 1997
Number of shared co-authors 17
Johns Hopkins University
Career Start Year 1996
Number of shared co-authors 18
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 2
Stanford University School of Medicine
Career Start Year 1993
Number of shared co-authors 10
Institute for Precision Cardiovascular Medicine
Career Start Year 1992
Number of shared co-authors 5
Cardiovascular Research Center, Massachusetts General Hospital
Career Start Year 1989
Number of shared co-authors 26
Charite University Medicine, Berlin Institute of Health (BIH)
Career Start Year 1988
Number of shared co-authors 3
University of Tennessee Health Science Center
Career Start Year 1986
Number of shared co-authors 17
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 36
and Blood Institute, National Institutes of Health
Career Start Year 1983
Number of shared co-authors 21
Mayo Clinic, Windland Smith Rice Genetic Heart Rhythm Clinic)
Career Start Year 1975
Number of shared co-authors 19
Northwestern University Feinberg School of Medicine
Career Start Year 1972
Number of shared co-authors 5

Collaborators

Stanford University
Co-authored papers 72
Co-authored papers 18
Co-authored papers 15
Stanford University
Co-authored papers 13
Co-authored papers 13
Ontario Institute for Cancer Research
Co-authored papers 10
Stanford University
Co-authored papers 10
Stanford University
Co-authored papers 9
Cardiovascular Institute, University of Colorado
Co-authored papers 7
University of Colorado Anschutz Medical Campus
Co-authored papers 7
Stanford Center for Undiagnosed Diseases
Co-authored papers 7
Stanford Medicine Clinical Genomics Program
Co-authored papers 6
Lucile Packard Children's Hospital and Stanford University
Co-authored papers 6
Stanford University
Co-authored papers 6
Center for Inherited Cardiovascular Disease, Stanford University School of Medicine
Co-authored papers 6
Stanford University
Co-authored papers 6
Stanford University
Co-authored papers 5
Stanford University
Co-authored papers 5
Stanford University School of Medicine
Co-authored papers 5
Harvard Medical School and Cardiovascular Division, Brigham and Women's Hospital
Co-authored papers 5
Stanford University
Co-authored papers 5
Co-authored papers 5
Bakar Computational Health Sciences Institute, University of California san francisco
Co-authored papers 4
J. David Gladstone Institutes
Co-authored papers 4
Stanford Center for Undiagnosed Diseases
Co-authored papers 4
Invitae Corporation
Co-authored papers 4
The Heart Institute, Cincinnati Children's Hospital Medical Center
Co-authored papers 3
Harvard Medical School
Co-authored papers 3
University of Washington
Co-authored papers 3
Stanford University
Co-authored papers 3